Prognostic impact of PHIP copy number in melanoma: Linkage to ulceration

Journal of Investigative Dermatology

Volumn 134, Issue 3, 2014, Pages 783-790

  Bezrookove, Vladimir ^a   De Semir, David ^a   Nosrati, Mehdi ^a   Tong, Schuyler ^a   Wu, Clayton ^a   Thummala, Suresh ^a   Dar, Altaf A ^a   Leong, Stanley P L ^a   Cleaver, James E ^b   Sagebiel, Richard W ^a   Miller, James R ^a   Kashani Sabet, Mohammed ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5; PLECKSTRIN HOMOLOGY DOMAIN INTERACTING PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; PLECKSTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CAPILLARY DENSITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TUMOR VASCULARIZATION; ULCER; ANGIOGENESIS; COHORT ANALYSIS; GENE EXPRESSION; HUMAN CELL CULTURE; PROGNOSIS; SKIN ULCER;

ADULT; AGED; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE DOSAGE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PROGNOSIS; SKIN NEOPLASMS; SKIN ULCER; TUMOR MARKERS, BIOLOGICAL;

EID: 84894053787     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.369     Document Type: Article

References (36)

1. Bagheri S, Nosrati M, Li S et al. (2006) Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci USA 103:11306- 111
2. Balch CM, Buzaid AC, Soong SJ et al. (2001a) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-488
3. Balch CM, Gershenwald JE, Soong S-J et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-2066
4. Balch CM, Soong SJ, Gershenwald JE et al. (2001b) Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-344
5. Baschong W, Suetterlin R, Laeng RH (2001) Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J Histochem Cytochem 49:1565-711
6. Bayani J, Squire JA (2004) Fluorescence in situ hybridization (FISH). Curr Protoc Cell Biol Chapter 22, Unit 22.4.1-22.4.522
7. Bonner MY, Arbiser JL (2012) Targeting NADPH oxidases for the treatment of cancer and inflammation. Cell Mol Life Sci 69:2435-422
8. Chin S-F, Daigo Y, Huang H-E et al. (2003) A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. MP, Mol Pathol 56: 275-99
9. Conway C, Mitra A, Jewell R et al. (2009) Gene expression profiling of paraffinembedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res 15:6939-466
10. Eggermont AMM, Suciu S, Testori A et al. (2012) Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 48: 218-255
11. Elstrom RL, Bauer DE, Buzzai M et al. (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892-99
12. Falk MS, Truitt AK, Coakley FV et al. (2007) Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Nucl Med Commun 28:273-800
13. Felcht M, Luck R, Schering A et al. (2012) Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122:1991-20055
14. Forsythe JA, Jiang BH, Iyer NV et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-133
15. Gogas H, Eggermont AMM, Hauschild A et al. (2009) Biomarkers in melanoma. Ann Oncol 20 Suppl 6:vi8-133
16. Halaban R, Cheng E, Zhang Y et al. (1997) Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci USA 94:6210-55
17. Halaban R, Patton RS, Cheng E et al. (2002) Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J Biol Chem 277:14821-88
18. Haqq C, Nosrati M, Sudilovsky D et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102:6092-77
19. Jalas JR, Vemula S, Bezrookove V et al. (2011) Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma. Am J Surg Pathol 35:1413-88
20. Kashani-Sabet M, Sagebiel RW, Ferreira CMM et al. (2002) Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 20:1826-311
21. Kashani-Sabet M, Venna S, Nosrati M et al. (2009) A multimarker prognostic assay for primary cutaneous melanoma. Clin Cancer Res 15:6987-922
22. Koukourakis MI, Giatromanolaki A, Sivridis E et al. (2003) Lactate dehydrogenase- 5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89:877-855
23. Lay AJ, Jiang XM, Kisker O et al. (2000) Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature 408:869-733
24. McArthur GA, Puzanov I, Amaravadi R et al. (2012) Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma. J Clin Oncol 30:1628-344
25. McMasters KM, Edwards MJ, Ross MI et al. (2010) Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg 252:460-55
26. Rangel J, Nosrati M, Torabian S et al. (2008) Osteopontin as a molecular prognostic marker for melanoma. Cancer 112:144-500
27. Rangel J, Torabian S, Shaikh L et al. (2006) Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. J Clin Oncol 24:4565-99
28. Reinhardt MJ, Joe AY, Jaeger U et al. (2006) Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 24:1178-877
29. De Semir D, Nosrati M, Bezrookove V et al. (2012) Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Proc Natl Acad Sci USA 109:7067-722
30. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-299
31. Thompson JF, Soong S-J, Balch CM et al. (2011) Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 29:2199-2055
32. Tsutsumi S, Yanagawa T, Shimura T et al. (2004) Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res 10:7775-844
33. Warburg O (1956) On the origin of cancer cells. Science 123:309-144
34. Wiegant J, Raap AK (2001) Probe labeling and fluorescence in situ hybridization. Curr Protoc Cytom Chapter 8, Unit 8.3.1-8.3.211
35. Winnepenninckx V, Lazar V, Michiels S et al. (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98:472-822
36. Zhuang L, Scolyer RA, Murali R et al. (2010) Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod Pathol 23:45-533